Reaching Remission, and Monitoring for Recurrence
- R&B singer Montell Jordan, 57, best known for his signature hit, “This Is How We Do It,” has navigated diagnosis, remission, recurrence, and a second remission from prostate cancer, crediting lifestyle changes and strong family support—especially from his wife Kristen—for helping him through the “roller coaster” journey.
- Jordan credits a combination of surgery preparation, 27 proton therapy treatments, and major lifestyle changes for his recovery, saying he feels great and is committed to doing what he can to prevent another recurrence.
- “Proton therapy has a physical property called the Bragg peak,” Dr. Alan Dal Pra, a radiation oncologist at Sylvester Comprehensive Cancer Center-University of Miami Health System, tells SurvivorNet.
- “This allows the radiation beam to enter the body, and there is a sharp fall-off. And when we develop the radiation volumes, the radiation field, this is able to spare more normal tissues,” Dr. Pra said.
- “Prostate cancer can progress rapidly after diagnosis, but can also become undetectable after curative intent radiation or surgery, only to recur years or decades later,” researchers wrote in the journal Cancer Letters.
Throughout the process, Montell and his wife, Kristen, embraced healthier habits together.


He describes the months that followed as a “roller coaster ride,” culminating in additional treatment last fall. Learning he was cancer‑free again just before Christmas felt like a gift.
“Surrounded by my kids and my grandkids, to get the call on that morning was surreal… It’s almost like it’s still unbelievable that we’re at this place right now, but we’re just super, super grateful,” he said.

Now, he’s channeling that gratitude into action.
“I’m 57, I feel great, and I am working out and eating right and doing the things I need to do to make sure the cancer does not return,” he shared — a mindset rooted in hope, discipline, and the desire to stay healthy for the long haul.
Expert Resources for Patients
- Monitoring After Prostate Cancer Treatment; How Is Recurrence Defined?
- Understanding Monitoring & Recurrence In Advanced Prostate Cancer
- The Option to Partake in a Clinical Trial During Recurrence
- ‘A Profound Effect’: Treating Advanced Prostate Cancer With Hormone Therapy
- Genetic Testing for Advanced Prostate Cancer Can Help Tailor Treatment
- How to Treat Late-Stage Prostate Cancer: New Treatment Developments
Better Understanding Jordon’s Proton Therapy Treatment
Proton beam therapy is a form of radiation therapy known as external beam radiation therapy. It works by using proton radiation that is sped up extremely fast and then precisely delivered to the tumor. When these particles reach the tumor, they deliver energy to the DNA, causing damage that kills the tumor cells.
“Proton therapy has a physical property called the Bragg peak,” Dr. Alan Dal Pra, a radiation oncologist at Sylvester Comprehensive Cancer Center-University of Miami Health System, tells SurvivorNet.
“This allows the radiation beam to enter the body, and there is a sharp fall-off. And when we develop the radiation volumes, the radiation field, this is able to spare more normal tissues,” Dr. Pra said.
Radiation therapy is typically given Monday through Friday, with weekends off to rest. The treatment is delivered externally and is completely non‑invasive—you won’t see, feel, or notice anything while it’s happening.
Each day, you’ll go to the radiation center and lie on a table using a custom mold—similar to a small bean bag—shaped specifically for your body and positioned around your hips.
This mold helps keep you still during treatment. Once the session is finished, you can resume your normal daily activities without any restrictions.
The proton beam therapy approach may be used for:
- Patients with localized prostate cancer who meet certain anatomic and insurance criteria
- Those seeking to reduce radiation dose to surrounding tissues (e.g., rectum or bladder)
- Men with prior pelvic radiation may benefit from proton’s precision
Advantages of proton therapy include the potential for fewer side effects due to less radiation dose to adjacent organs, a reduction in long-term risks of secondary cancers in younger patients, and it can be technically advantageous in patients with challenging anatomy.
View this post on Instagram
Jordan’s Cancer Journey Enters a New Phase: Survivorship
Jordan first revealed his diagnosis in December 2024, nearly a year after doctors began monitoring his rising PSA levels.
The prostate-specific antigen test (PSA) measures the prostate-specific antigen in the blood. An elevated PSA level in the blood does not always mean you have prostate cancer, but it does call for further tests.
RELATED: Check Out SurvivorNet’s Digital Guide to Prostate Cancer.
“My initial reaction was, I didn’t feel any different, and I didn’t have any symptoms,” he explained to the “Today Show.” “For the decade, I had received regular check-ups, but over time, my doctors noticed that my PSA numbers had been increasing.”
That vigilance led to a diagnosis of Gleason 6 prostate cancer—considered low risk but still requiring attention. “I was first diagnosed with Gleason 6,” Jordan said, referring to the scoring system that helps determine the aggressiveness of prostate cancer.
The results of the PSA test provide a Gleason Score. This score ranges from 6 to 10. The higher the score, the more aggressive the cancer. This score, along with other test results, helps doctors determine if cancer is “low risk,” “intermediate risk,” or “high risk.”
WATCH: How Gleason Grade Determines Treatment
Jordan opted for a prostatectomy, a surgical procedure that removes the prostate and surrounding tissue. Though the surgery came with potential side effects like erectile dysfunction and urinary incontinence, Jordan remained focused on recovery.
“Post-treatment, I’m doing well. I’m still going to get regular check-ups,” Jordan said.
Why Prostate Cancer Can Return
Prostate cancer recurrence is not all that uncommon. A study published in the medical journal JAMA followed 1,997 men who had undergone prostate removal surgery. Of those, 304 experienced a recurrence, and about 25% of those cases occurred five or more years after surgery.
Researchers believe that dormant cancer cells can hide in the body for years. The bone marrow, in particular, is considered a key hiding place. This is supported by findings published in the International Journal of Cancer, which noted, “In one autopsy study, approximately 80% of the men who had died from prostate cancer possessed bone metastases.”
Other potential reservoirs for dormant cancer cells include the lymph nodes and the prostate bed—the area where the prostate gland once was—though these are more difficult to study.
Researchers have made significant strides in understanding how prostate cancer can spread early—even when it appears to be under control—and then return months or even years later. One key discovery is that the bones are a common site for prostate cancer to spread. In fact, scientists have found dormant cancer cells hiding in the bone marrow of many patients, even when the disease seems confined to the prostate.
Lab studies, mostly using model systems, have also helped uncover how prostate cancer cells can lie dormant for long periods before becoming active again. While treatments like hormone therapy and radiation after surgery have shown promise, experts agree that more research—both in the lab and in clinical trials—is needed to improve outcomes for patients.
Prostate Cancer Screening and Warning Signs
When you do get screened for prostate cancer, your doctor will run a few tests.
One of the tests is the PSA test, a simple blood test that screens for prostate cancer. It looks for more significant amounts of protein-specific antigen (PSA) in the blood. An elevated PSA test does not always mean you have prostate cancer. It could also reflect that your prostate is enlarged, which is common, or it could signal an infection or inflammation.
Your doctor may also conduct a digital rectal exam (DRE) to check your prostate for lumps.
Depending on the results of these tests, imaging scans and a biopsy may be ordered.
WATCH: How Gleason Grade Determines Treatment
Prostate cancer does not always behave the same in every man it impacts. The cancer can be considered “low-risk” and can be slow-growing, and treatment might not be necessary. In other men, the cancer may grow faster or more aggressively, requiring more immediate treatment. Because of this, there is some debate about screening.
The United States Preventive Services Task Force recommends that men at average risk between the ages of 55 and 69 years talk with their doctor about the pros and cons of prostate cancer screening.
The American Cancer Society recommends that men at age 50 who are at average risk should begin screening. Men who are at high risk of prostate cancer should begin screening at age 40. Men with a close relative diagnosed with prostate cancer should consider annual screenings in their 30s.
SurvivorNet experts suggested that men consider factors like their family history, genes, and age when deciding whether and when to screen.
Symptoms of prostate cancer may include:
- Urinating more often
- Waking up in the middle of the night to pee
- Blood in your urine
- Trouble getting an erection
- Pain or burning when you urinate
- Pain in your back, hips, thighs, or other bones
- Unexplained weight loss
- Fatigue
If You’re Diagnosed With Prostate Cancer, What to Expect for Treatment?
After testing and establishing your risk, your doctor will discuss possible treatment options. These may range from active surveillance to more aggressive options, including surgery and radiation therapy.
WATCH: Coping emotionally after a prostate cancer diagnosis
Surgery is an option for men with any risk group of prostate cancer that hasn’t spread outside of the prostate gland. The type of surgery most often used is called a radical prostatectomy.
During the procedure, the surgeon removes the entire prostate, along with some tissue around it, including the seminal vesicles that release fluid into the semen. Your doctor can perform this through a traditional open procedure with one large or several small incisions, called laparoscopic surgery.
WATCH: Sexual Function Recovery After Prostate Cancer Surgery
Surgery side effects may include erectile dysfunction and urinary incontinence. Fortunately, the side effects are usually temporary, and there are ways to help you manage them.
“Erectile function is so sensitive when we’re dealing with prostate cancer because the nerves that are critical for this function wrap around the prostate; they’re just so intimately connected to the prostate that they can be damaged from a surgical removal of the prostate or through radiation treatment,” Dr. Isla Garraway, a staff urologist in the Veterans Administration (VA) Greater Los Angeles Healthcare System, told SurvivorNet.
Doctors often recommend sexual counseling after prostate cancer treatment to help improve sexual function. This approach actively addresses the psychological, emotional, and relationship impacts on sexual health.
Radiation therapy is often done when prostate cancer is caught early and confined to the prostate gland.
Questions for Your Doctor
If you have experienced symptoms associated with prostate cancer or have a screening coming up, here are some questions you may ask your doctor:
- If I had elevated PSA levels, what could be causing that besides cancer?
- How long will it take to learn if my PSA levels warrant further testing?
- What are the treatment options that are best suited for me based on my risk level?
- What financial resources exist to help me with the costs associated with treatment?
- How long will my potential treatment prevent me from working or continuing normal activities?
Learn more about SurvivorNet's rigorous medical review process.
